Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.
Salar
Antonio
A
Bessa
Xavier
X
Muñiz
Eduard
E
Monfort
David
D
Besses
Carlos
C
Andreu
Montserrat
M
D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001772:Blood Cell Count; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D013921:Thrombocytopenia / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab